what are the side effects of a glp 1 Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, effects, and risks What to Expect After First

The drastic inhibition of GLP-1 secretion via shutdown of the main pathway is the primary cause of pasireotide-induced hyperglycemia

C/EBP, CCAAT/enhancer binding protein

There are varieties of studies that confirm this conclusion

For short-term or mild adverse events, dietary modifications are warranted and, for constipation, increased fiber/water intake can be recommended

GLP-1 medications do not directly damage the eyes, but may worsen pre-existing diabetic retinopathy in patients who experience rapid blood glucose improvements

Both medications follow predictable patterns, but the experience differs significantly between the two